Hay fever
Conditions
Interventions
Use ALA01 in addition to prescribed hay fever medications.
Use only prescribed hay fever medications.
Sponsors
Juntendo University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients with NSS score between 3 and 10 and NNSS score between 3 and 8 on Day 0. (2) Patients who can understand and agree to the consent form (3) Patients who can operate a smart phone (4) Patients who are 20 years of age or older
Exclusion criteria
Exclusion criteria: (1) Those who are deemed inappropriate as research subjects by the principal investigator (2) Those who could not give their consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The following items at 4 weeks after the inclusion time point (Day 0) Hay fever subjective symptom assessment: Nasal symptom score (NSS), Non-nasal symptom score (NNSS), Total symptom score (TSS), and Allergic Conjunctival Quality of Life Questionnaire (JACQLQ) Domain II score2 | — |
Secondary
| Measure | Time frame |
|---|---|
| The following items at 4 weeks after the inclusion time point (Day 0) (1) Basic information on research subjects: age, sex, diagnosis, duration of disease, treatment details (drugs used, duration of treatment) (2) Allergy test results (3) Medication adherence assessment: Medication adherence scale (MMAS-8) (4) Medication record (5) Viewing status of educational contents in the application (6) Operability evaluation | — |
Countries
Japan
Contacts
Public ContactTakenori Inomata
Juntendo University Graduate School of Medicine, Department of Ophthalmology
Outcome results
None listed